Clinical Trial Update: Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 1/Phase 2 study evaluating subtenon autologous platelet-rich plasma for inherited and degenerative retinal diseases, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive Macular Atrophy with Pseudodrusen
• Retinitis Pigmentosa

Drugs mentioned

• Subtenon Autologous Platelet-Rich Plasma

Snippet

Sponsor: Rubens Camargo Siqueira | Conditions: Extensive Macular Atrophy With Pseudodrusen (EMAP), Retinitis Pigmentosa (RP) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING